Artificial pancreas for newly diagnosed type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests whether an automated insulin delivery system (artificial pancreas) can help people recently diagnosed with type 1 diabetes manage their blood sugar better. The goal is to see if early use of this technology can preserve the body's ability to make some insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have just been diagnosed with type 1 diabetes.
- A blood test shows you have the antibodies (markers) that confirm type 1 diabetes.
- You are not pregnant.
- You do not have an active cancer or other serious illness that would make it hard to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
This study compares a new automated insulin delivery algorithm (AIDANET) in two modes: fully closed-loop (no user input needed) versus hybrid closed-loop (user still gives some insulin for meals). It tests how well the algorithm works in real-life settings for adults with type 1 diabetes.
This study tests an automated insulin delivery system within 2 weeks of a type 1 diabetes diagnosis to see if it helps manage blood sugar early on. It is for patients who will get their diabetes care at Stanford Children's Hospital.
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests whether starting automated insulin delivery (a system that adjusts insulin automatically) early after diagnosis helps children and teens with type 1 diabetes manage their blood sugar better. It also looks at long-term health and costs.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.